Preston Holb

Preston Holb, CPA, is currently a financial consultant in the Bio-Medicines business unit at Eli Lilly and Company. Previously, Holb served as Executive Director - US Oncology Finance at Eli Lilly, after holding roles at Deloitte, where they played a pivotal role in budget execution and strategic sourcing. Holb co-founded the Global Impact Collective, contributing significantly to nonprofit efforts across multiple countries. Earlier experience includes various financial and analytical positions at Raytheon, Boeing, and Katz, Sapper & Miller, showcasing a strong foundation in finance and leadership. Holb is also pursuing education at Northwestern University's Kellogg School of Management.